Pharmacy Residency - More Information

Scholarly activity and application guidelines

Scholarly Activity

Papers and Presentations

Our faculty and students make research a priority, as evidenced by our archive of publications and presentations.

TEAM	TOPIC	FORUM
Adrianna Goodin, PharmD; Alyssa Robertson, PharmD, BCCCP; Matt Walbrown, PharmD, BCPS	Urinary Pathogens, Resistance Patterns, and Empiric Antibiotic Selection in Patients Presenting to Community Teaching Hospital Emergency Department	WellSpan Discovery Day and Eastern States Conference
Ashley Myers, PharmD; Natasha Advani, PharmD; Karen Frock, PharmD, BCCCP	Evaluation of Pharmacist Interventions During Transitions of Care from Intensive Care Units	WellSpan Discovery Day and Eastern States Conference
Leah Deroche, PharmD; Alison Sabados, PharmD, BCCCP; Chelsea Laughner, PharmD, BCPS	Improved Adherence to Norepinephrine Titration Instructions Within a Community Health System	WellSpan Discovery Day and Eastern States Conference
Gina Lee, PharmD; Alison Sabados, PharmD, BCCCP; Karen Frock, PharmD, BCCCP	Comparison of Argatroban and Bivalirudin Protocols for the Treatment of Heparin-Induced Thrombocytopenia	WellSpan Discovery Day and Eastern States Conference
Adrianna Goodin, PharmD; Alison Sabados, PharmD, BCCCP; Dalton Fishel, PharmD BCCCP	Hemostatic efficacy of fixed-dose prothrombin complex concentrate for warfarin and oral factor Xa inhibitor reversal	WellSpan Discovery Day and Eastern States Conference
Casey DeLuca, PharmD, MBA; Karen Frock, PharmD, BCCCP; Chelsea Laughner, PharmD, BCPS	Safety of unfractionated heparin protocol for the treatment of venous thromboembolism based on body mass index	WellSpan Discovery Day and Eastern States Conference
Camryn Shope, PharmD, MPGPM; Geoffrey Arentz, PharmD, BCPS; Duy Nguyen, PharmD, BCPS; Robert Patti, PharmD, JD	Impact of SGLT2 inhibitor treatment on heart failure readmission rate	WellSpan Discovery Day and Eastern States Conference
Paige Moreno, PharmD; Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP; Matthew Walbrown, PharmD	Evaluation of daptomycin as preferred therapy for skin and soft tissue infections	WellSpan Discovery Day and Eastern States Conference

TEAM	TOPIC	FORUM
Adrianna Goodin, PharmD; Alyssa Robertson, PharmD, BCCCP; Matt Walbrown, PharmD, BCPS	Urinary Pathogens, Resistance Patterns, and Empiric Antibiotic Selection in Patients Presenting to Community Teaching Hospital Emergency Department	WellSpan Discovery Day and Eastern States Conference
Ashley Myers, PharmD; Natasha Advani, PharmD; Karen Frock, PharmD, BCCCP	Evaluation of Pharmacist Interventions During Transitions of Care from Intensive Care Units	WellSpan Discovery Day and Eastern States Conference
Leah Deroche, PharmD; Alison Sabados, PharmD, BCCCP; Chelsea Laughner, PharmD, BCPS	Improved Adherence to Norepinephrine Titration Instructions Within a Community Health System	WellSpan Discovery Day and Eastern States Conference
Gina Lee, PharmD; Alison Sabados, PharmD, BCCCP; Karen Frock, PharmD, BCCCP	Comparison of Argatroban and Bivalirudin Protocols for the Treatment of Heparin-Induced Thrombocytopenia	WellSpan Discovery Day and Eastern States Conference
Adrianna Goodin, PharmD; Karen Frock, PharmD, BCCCP; Dalton Fishel, PharmD, BCCCP	Caloric intake in critically ill patients receiving total parenteral nutrition: adherence to guideline recommendations	ASHP Midyear
Casey DeLuca, PharmD, MBA; Alison Sabados, PharmD, BCCCP; Jennifer Sullivan, PharmD; Chelsea Laughner, PharmD, BCPS; Theresa Langeheine, PharmD, BCPS	Evaluation of subcutaneous methylnaltrexone use in a community health system	ASHP Midyear
Camryn Shope, PharmD, MPGPM; Brittany Thomas, PharmD, BCPS, BCIDP; Matthew Crouse, PharmD, BCPS; Kevin Davis, PharmD	Evaluation of empiric vancomycin in patients with febrile neutropenia	ASHP Midyear
Paige Moreno, PharmD; Geoffrey Arentz, PharmD, BCPS; Christine Higgins, PharmD, BCPS; Natasha Advani, PharmD	Evaluation of vitamin K administration for warfarin reversal	ASHP Midyear

TEAM	TOPIC	FORUM
Adrianna Goodin, PharmD; Christine Higgins, RPh, BCPS; Benson Mathew, PharmD, BCPS; Alisha Mutch, PharmD, BCPS	Evaluation of Intravenous Acetaminophen Restrictions at a Community Health System	ASHP Midyear
Leah Deroche, PharmD; Karen Frock, PharmD, BCCCP; Matthew S. Crouse, PharmD, BCPS	Evaluation of Alvimopan Usage within a Community Health System	ASHP Midyear
Ashley Myers, PharmD; Alyssa Robertson, PharmD, BCCCP; Dalton Fishel, PharmD, BCCCP	Evaluation of Insulin Use for Hyperkalemia Management Within a Community Health System	ASHP Midyear
Gina Lee, PharmD; Brittany Thomas, PharmD, BCPS, BCIDP; Aundrea Rosenberger, PharmD, BCIDP	Evaluation of Metronidazole Prescribing in Community Acquired Pneumonia	ASHP Midyear
Trent D Gray Jr., PharmD, MSPH	CODEWAR: Impact of COVID-19 on Warfarin Requirements	WellSpan Discovery Day and Eastern States Conference
Joan Kariuki, PharmD; Joseph DiBlasi, PharmD, BCPS, MBA; Alison Sabados, PharmD, BCCCP	Evaluation of Albumin Use and Cost in a Community Teaching Hospital	WellSpan Discovery Day and Eastern States Conference
Jacob Gregory, PharmD; Alison Sabados, PharmD, BCCCP; Chelsea Laughner, PharmD, BCPS	Comparison of Sedation Practices Before and During the COVID-19 Pandemic	WellSpan Discovery Day and Eastern States Conference
Alison Panchisin, PharmD; Joseph DiBlasi, PharmD, BCPS, MBA; Geoffrey Arentz, PharmD, BCPS	Evaluation of Seizure Prophylaxis in Subarachnoid Hemorrhage	WellSpan Discovery Day and Eastern States Conference

TEAM	TOPIC	FORUM
Jacob Gregory, PharmD; Alison Sabados, PharmD, BCCCP; Jennifer Sullivan, PharmD, BCCCP	Assessment of Sodium Bicarbonate Use in a Community Teaching Hospital	ASHP Midyear
Alison Panchisin, PharmD; Jennifer Sullivan, PharmD; Alyssa Robertson, PharmD, BCCCP	Adherence with Post-droperidol Administration Safety Monitoring	ASHP Midyear
Joan Kariuki, PharmD; Aundrea Rosenberger, PharmD, BCIDP; Golda Peysakhova, PharmD; Natasha Advani, PharmD	Impact of Vancomycin Order Questionnaire on Appropriate Prescribing for Community Acquired Pneumonia	ASHP Midyear
Trent D Gray Jr., PharmD	Evaluation of Treatment Duration of Community Acquired Pneumonia within WellSpan Health System	ASHP Midyear
Taylor Groff, PharmD; Yasmeen Alcheikh, PharmD, BCPS; Alison Sabados, PharmD, BCCCP	Pharmacist-Driven Statin Optimization in Hospitalized Patients with Atherosclerotic Cardiovascular Disease or Diabetes Mellitus	WellSpan Discovery Day and Eastern States Conference
Emily Kistler, PharmD, BCPS	Impact of a Collaborative Penicillin Allergy Assessment Initiative in a Community Teaching Hospital	WellSpan Discovery Day and Eastern States Conference
Golda Peysakhova, PharmD; Alisha Mutch, PharmD, BCPS; Jennifer Sullivan, PharmD	Evaluation of Pharmacist Intervention at Transitions of Care for COPD Admissions	WellSpan Discovery Day and Eastern States Conference
Teresa Benites, PharmD, BCCCP; Geoffrey Arentz, PharmD, BCPS; Alison Sabados, PharmD, BCCCP	Evaluation of Quetiapine Use During Transitions of Care from the Intensive Care Unit	WellSpan Discovery Day & Eastern States Conference

TEAM	TOPIC	FORUM
Rania Ayad, PharmD; Dalton Fishel, PharmD, BCCCP; Karen Frock, PharmD, BCCP	Evaluation of the Continuation of Newly Initiated Midodrine After ICU and Hospital Discharge	WellSpan Discovery Day and Eastern States Conference
Nicole Ayers, PharmD; Alison Sabados, PharmD, BCCCP; Chelsea Laughner, PharmD, BCPS	Safety of Heparin Infusions for Cardiac Indications at a Community Teaching Hospital	WellSpan Discovery Day and Eastern States Conference
Erica Little, PharmD; Jennifer Sullivan, PharmD, BCCCP	Evaluation of Buprenorphine in Opioid Use Disorder at a Community Teaching Hospital	WellSpan Discovery Day and Eastern States Conference
Kayla Bardzel, PharmD; Dalton Fishel, PharmD, BCCCP; Brenna Simcoe, PharmD, BCCCP	Evaluation of Pharmacist Intervention on Management of Pain and Agitation in the Intensive Care Unit	WellSpan Discovery Day and Eastern States Conference
Golda Peysakhova, PharmD; Geoffrey Arentz, PharmD, BCPS; Alison Sabados, PharmD, BCCCP	Evaluation of Anticoagulation in Critically Ill Patients with COVID-19
Taylor Groff, PharmD; Jennifer Sullivan, PharmD; Karli Swartz, PharmD, BCPS	Appropriateness of Dual Antiplatelet Therapy for Patients with a Bleeding Event
Rania Ayad, PharmD; Karen Frock, PharmD, BCCCP	Evaluation of the Continuation of Newly Initiated Midodrine after ICU and Hospital Discharge
Emily Kistler, PharmD, BCPS	Appropriateness of As-needed Pain Management on a Medical-Surgical Unit

TEAM	TOPIC	FOCUS
Kristen Cicchillo, PharmD; Molly Walbrown, PharmD, BCPS, CACP, CDE	Steroid-Induced Hyperglycemia in Non-Diabetic COPD Patients	WellSpan Discovery Day and Eastern States Conference
Yasmeen Alcheikh, PharmD; Jennifer Sullivan, PharmD, BCCCP	Evaluation of Adherence to HIV Antiretroviral Therapy in Hospitalized Patients at WellSpan York Hospital	WellSpan Discovery Day and Eastern States Conference
Sarah White, PharmD; Alison Sabados, PharmD, BCCCP; Karen Frock, PharmD, BCCP	Frequency of Delayed Initiation and Missed Doses of Venous Thromboembolism Chemoprophylaxis in Adult Orthopedic Trauma Patients	WellSpan Discovery Day and Eastern States Conference
Dalton Fishel, PharmD; Brenna Simcoe, PharmD, BCCCP	Retrospective Evaluation of Variable-Dose Versus Fixed-Dose 4-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal	WellSpan Discovery Day and Eastern States Conference
Rania Ayad, PharmD; Geoffrey Arentz, PharmD; Jennifer Sullivan, PharmD, BCCCP	Evaluating the Need for Anti-Xa Monitoring with Therapeutic Enoxaparin Dosing in Patients with Extreme Body Weights and Renal Dysfunction	ASHP Midyear
Nicole Ayers, PharmD; Alison Sabados, PharmD, BCCCP	Evaluation of Inpatient Immune Globulin in a Community Health System	ASHP Midyear
Erica Little, PharmD; Aundrea Rosenberger, PharmD, BCIDP; Brittany Thomas, PharmD, BCPS	Evaluation of Initial Treatment Regimens for Clostridioides Difficile in Hospitalized Patients	ASHP Midyear
Kayla Bardzel, PharmD; Jennifer Sullivan, PharmD, BCCCP	Pushing the Subject: Push-Dose Epinephrine and Phenylephrine in the Emergency Department at a Community Teaching Hospital	ASHP Midyear

Application procedure for PGY-1 and PGY-2 programs

Deadline: Jan. 6

To be eligible, all applicants must:

possess a Doctor of Pharmacy degree from an accredited school or college of pharmacy
possess a license or be eligible for licensure by the Pennsylvania State Board of Pharmacy
participate in an interview at WellSpan York Hospital

Please submit the following to the Pharmacy Online Residency Centralized Application Service (PhORCAS). All applications must be complete on or before Jan. 6 for consideration.

applicant information (contact and personal information)
educational information
personal statement or letter of intent
curriculum vitae
official transcript
three references, submitted using the PhORCAS reference form. References should be from rotation preceptors or employers who have directly supervised the candidate.

All candidates are encouraged to visit the Pennsylvania State Board of Pharmacy's website.

For PGY-2 candidates, application requirements include successful completion of a PGY-1 Pharmacy Residency Program at WellSpan York Hospital.

We recognize and honor the diversity of our team members, patients and neighbors, and we embrace all the human characteristics that make us both similar and unique. We strive to make every person feel welcomed, respected, and valued by creating a safe and inclusive environment to which we all feel a sense of belonging. We’re committed to making sure all team members have equal opportunities to excel and are positioned for success through equitable policies, practices and resources.

Notice of Rights Under Federal Conscience and Anti-Discrimination Laws

WellSpan Health and all WellSpan Hospitals comply with applicable Federal conscience and antidiscrimination laws prohibiting exclusion, adverse treatment, coercion, or other discrimination against individuals or entities on the basis of their religious beliefs or moral convictions. You may have the right under Federal law to decline to perform, assist in the performance of, refer for, undergo, or pay for certain health care-related treatments, research, or services (such as abortion or assisted suicide, among others) that violate your conscience, religious beliefs, or moral convictions.

If you believe that WellSpan Health or any WellSpan Health Hospital has failed to accommodate your conscientious, religious, or moral objection, or has discriminated against you on those grounds, you can file a conscience and religious freedom complaint with the U.S. Department of Health and Human Services, Office for Civil Rights, electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf or by mail or phone at: U.S. Department of Health and Human Services, 200 Independence Avenue SW, Room 509F, HHH Building Washington, DC 20201, 1–800–368–1019, 800–537–7697 (TDD). Complaint forms and more information about Federal conscience and anti-discrimination laws are available at http://www.hhs.gov/conscience.

A copy of the complete rule and OCR’s explanatory text, as published in the Federal Register, is available at: https://www.govinfo.gov/content/pkg/FR-2019-05-21/pdf/2019-09667.pdf.

Your Privacy Matters to WellSpan

Set Your Location

Featured Searches

Featured Searches

Pharmacy Residency - More Information

Scholarly activity and application guidelines

Your Privacy Matters to WellSpan

Share This Page